Screening for psychosocial distress in pediatric cancer patients: An examination of feasibility in a single institution.


Journal

Pediatric hematology and oncology
ISSN: 1521-0669
Titre abrégé: Pediatr Hematol Oncol
Pays: England
ID NLM: 8700164

Informations de publication

Date de publication:
Apr 2019
Historique:
pubmed: 16 4 2019
medline: 18 12 2019
entrez: 16 4 2019
Statut: ppublish

Résumé

Despite the availability of tools to assess psychosocial screening in pediatric oncology, little is known about the feasibility and acceptability of systematic screening. We aimed to assess the feasibility of implementing a tool, or set of tools, capable of screening for psychosocial distress in pediatric cancer patients across the cancer continuum (on treatment, off treatment). Psychometric criteria were also evaluated. Patients 8-18 years were recruited from a pediatric oncology program. Patients completed self-report measures of the Distress Thermometer (DT) and Pediatric Quality of Life Inventory (PedsQL). One parent of each patient completed three screening tools: DT (proxy-report); PedsQL (proxy-report), and the Psychosocial Assessment Tool adapted for the Canadian context (PATrev), as well as a measure of patient psychological functioning (Behavioral Assessment System for Children-2), and an assessment of screening tool acceptability. Recruitment rates and acceptability informed feasibility of implementation. Ninety-five patients (58 men) with a mean age of 11.47 participated in the study (on treatment,

Identifiants

pubmed: 30983467
doi: 10.1080/08880018.2019.1600082
doi:

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

125-137

Auteurs

Fiona Schulte (F)

a Department of Oncology , Cumming School of Medicine, University of Calgary , Alberta , Canada.
b Haematology, Oncology and Transplant Program , Alberta Children's Hospital , Alberta , Canada.

K Brooke Russell (KB)

c Department of Psychology , Faculty of Arts, University of Calgary , Alberta , Canada.

Wendy Pelletier (W)

b Haematology, Oncology and Transplant Program , Alberta Children's Hospital , Alberta , Canada.

Laura Scott-Lane (L)

b Haematology, Oncology and Transplant Program , Alberta Children's Hospital , Alberta , Canada.

Gregory M T Guilcher (GMT)

a Department of Oncology , Cumming School of Medicine, University of Calgary , Alberta , Canada.
b Haematology, Oncology and Transplant Program , Alberta Children's Hospital , Alberta , Canada.
d Department of Pediatrics , Cumming School of Medicine, University of Calgary , Alberta , Canada.

Douglas Strother (D)

a Department of Oncology , Cumming School of Medicine, University of Calgary , Alberta , Canada.
b Haematology, Oncology and Transplant Program , Alberta Children's Hospital , Alberta , Canada.
d Department of Pediatrics , Cumming School of Medicine, University of Calgary , Alberta , Canada.

Deborah Dewey (D)

d Department of Pediatrics , Cumming School of Medicine, University of Calgary , Alberta , Canada.
e Department of Community Health Sciences , Cumming School of Medicine, University of Calgary , Alberta , Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH